GlassScriptPhysician profile
Kathryn L Dawson
NPI 1477997724
$56,949.52
in general payments reported to CMS, 2019-2025
13 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2021: $20K · 2022: $621 · 2023: $3,580 · 2024: $1,560 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $6,925 · Travel and Lodging: $5,691 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,500.00 |
| Food and Beverage | $6,924.50 |
| Travel and Lodging | $5,691.08 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $28,346.85 | 2025 | Optis |
| Boston Scientific Corporation | $21,845.66 | 2019-2025 | Avvigo Guidance System, Stingray, General - Atherectomy |
| Medtronic, INC. | $2,578.33 | 2022-2025 | Resolute Onyx, Onyx Frontier, Corevalve Evolut R |
| Asahi Intecc USA, INC. | $1,273.92 | 2023-2025 | Asahi Coronary Wires, Asahi Ptca Guide Wire, Peripheral Vascular |
| Teleflex LLC | $1,073.92 | 2024-2025 | Manta, Turnpike, Guideliner |
| Shockwave Medical, INC | $713.28 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $654.92 | 2022-2025 | Impella |
| Arrow International, INC. | $172.94 | 2024 | Guideliner |
| Biotronik INC. | $118.12 | 2023 | |
| Reflow Medical INC | $80.95 | 2023 | |
| Edwards Lifesciences Corporation | $48.59 | 2024 | Sapien 3 Ultra Resilia |
| Becton, Dickinson and Company | $22.31 | 2025 | Lutonix Drug Coated Balloon |
| Janssen Pharmaceuticals, INC | $19.73 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.